Kimi Iguchi News Today

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q4 2023 Earnings Call Transcript February 14, 2024 Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to SAGE Therapeutics’ Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator […]

Operator: Good morning. Welcome to Sage Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions].

Shares of Sage Therapeutics slumped to a record low on Monday after the U.S. health regulator approved the company and partner Biogens pill for postpartum depression, but rejected it as a...

Operator: Good morning. Welcome to the Sage Therapeutics Fourth Quarter and Full-Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode.

Sage Therapeutics, Inc. (NASDAQ:NASDAQ:SAGE) Q1 2022 Earnings Conference Call May 03, 2022 08:00 AM ET Company Participants Helen Rubinstein - Investor Relations Barry Greene - Chief...

SAGE earnings call for the period ending September 30, 2021.

Operator Good morning. Welcome to Sage Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the investor and media section of Sages website at sagerx.com. This call is property of Sage Therapeutics and recording, reproduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited. Please note this call is being recorded. I would now like to introduce Jeff Boyle, Vice ...